Protective Effect of Ellagic Acid Against Sodium Arsenite-Induced Cardio- and Hematotoxicity in Rats
Ellagic acid (EA) is a phenolic constituent in certain fruits and nuts with wide range of biological activities, including potent antioxidant, antidiabetic, anti-inflammatory, anticancer and antimutagen properties. The aim of this study was to evaluate the effect of EA on sodium arsenic (SA)-induced cardio- and hematotoxicity in rats. Animals were divided into five groups. The first group was used as control. Group 2 was orally treated with sodium arsenite (SA, 10 mg/kg) for 21 days. Group 3 was orally treated with EA (30 mg/kg) for 14 days. Groups 4 and 5 were orally treated with SA for 7 days prior to EA (10 and 30 mg/kg, respectively) treatment and continued up to 21 days simultaneous with SA administration. Various biochemical, histological and molecular biomarkers were assessed in blood and heart. The results indicate that SA-intoxicated rats display significantly higher levels of plasma cardiac markers (AST, CK-MB, LDH and cTnI) than normal control animals. Moreover, an increase in MDA and NO with depletion of GSH and activities of CAT, SOD and GPx occurred in the heart of rats treated with SA. Furthermore, SA-treated rats showed significantly lower WBC, RBC, HGB, HCT and PLT and significantly higher MCV and MCH. Administration of EA (30 mg/kg) resulted in a significant reversal of hematological and cardiac markers in arsenic-intoxicated rats. These biochemical disturbances were supported by histopathological observations of the heart. In conclusion, the results of this study suggest that EA treatment exerts a significant protective effect on SA-induced cardio- and hematotoxicity.
KeywordsSodium arsenite Ellagic acid Hematological parameters Cardioprotection Rat
This study was funded by Deputy of Research of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (Grant Number 95s35).
Compliance with Ethical Standards
Conflict of interest
Authors declare no conflict of interest related to this study.
- 8.Abu El-Saad, A. M., Al-Kahtani, M. A., & Abdel-Moneim, A. M. (2016). N-acetylcysteine and meso-2,3-dimercaptosuccinic acid alleviate oxidative stress and hepatic dysfunction induced by sodium arsenite in male rats. Drug Design, Development and Therapy, 10, 3425–3434.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.El-Shitany, N. A., El-Bastawissy, E. A., & El-desoky, K. (2014). Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor kappa B, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant mechanism. International Immunopharmacology, 19, 290–299.CrossRefPubMedGoogle Scholar
- 19.Al-Hasan, A. K. J. (2017). Effects of low-and high-level pulsed Nd: YAG laser irradiation on red blood cells and platelets indices of albino rats in vitro. Iraq Medical Journal, 1, 10–19.Google Scholar
- 27.Tracey, W. R., Linden, J., Peach, M. J., & Johns, R. A. (1990). Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): Nonspecificity of the diazotization reaction for NO and failure to detect EDRF. Journal of Pharmacology and Experimental Therapeutics, 252, 922–928.PubMedGoogle Scholar
- 32.Priyamvada, S., Priyadarshini, M., Arivarasu, N., Farooq, N., Khan, S., Khan, S. A., et al. (2008). Studies on the protective effect of dietary fish oil on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Prostaglandins Leukotrienes and Essential Fatty Acids, 78, 369–381.CrossRefGoogle Scholar
- 37.Hemmati, A. A., Olapour, S., Varzi, H. N., Khodayar, M. J., Dianat, M., Mohammadian, B., and Yaghooti, H. (2017). Ellagic acid protects against arsenic trioxide-induced cardiotoxicity in rat. Human & Experimental Toxicology 960327117701986.Google Scholar